Bioteque Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Bioteque şirketinin toplam hissedar öz sermayesi NT$3.2B ve toplam borcu NT$530.1M olup, bu da borç-öz sermaye oranını 16.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NT$4.8B ve NT$1.7B dir. Bioteque 'in FAVÖK'ü NT$621.0M faiz karşılama oranı -264.1 dur. Şirketin NT$1.8B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

16.8%

Borç/özkaynak oranı

NT$530.14m

Borç

Faiz karşılama oranı	-264.1x
Nakit	NT$1.76b
Eşitlik	NT$3.16b
Toplam yükümlülükler	NT$1.68b
Toplam varlıklar	NT$4.84b

Son finansal sağlık güncellemeleri

Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet

Jan 10

Recent updates

A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)

Apr 26

Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?

Mar 29

Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 11

Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Dec 10

Will Bioteque (GTSM:4107) Multiply In Value Going Forward?

Nov 22

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4107 'nin kısa vadeli varlıkları ( NT$2.4B ) kısa vadeli yükümlülüklerini ( NT$969.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: 4107 şirketinin kısa vadeli varlıkları ( NT$2.4B ) uzun vadeli yükümlülüklerini ( NT$714.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4107 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 4107 şirketinin borç/öz sermaye oranı son 5 yılda 3.7% seviyesinden 16.8% seviyesine yükseldi.

Borç Kapsamı: 4107 'nin borcu işletme nakit akışı ( 150.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 4107 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Bioteque Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet

Recent updates

Bioteque Corporation to Report Q3, 2024 Results on Nov 07, 2024

Second quarter 2024 earnings released: EPS: NT$1.80 (vs NT$1.48 in 2Q 2023)

Bioteque Corporation to Report Q2, 2024 Results on Aug 07, 2024

Upcoming dividend of NT$4.50 per share

First quarter 2024 earnings released: EPS: NT$1.81 (vs NT$1.42 in 1Q 2023)

Bioteque Corporation Announces Cash Dividend, Payable on August 30, 2024

Bioteque Corporation to Report Q1, 2024 Results on May 09, 2024

Bioteque Corporation to Report Q1, 2024 Results on May 09, 2024

Bioteque Corporation Announces Board Changes

Full year 2023 earnings released: EPS: NT$6.53 (vs NT$7.12 in FY 2022)

Bioteque Corporation, Annual General Meeting, Jun 19, 2024

Third quarter 2023 earnings released: EPS: NT$2.11 (vs NT$1.93 in 3Q 2022)

Now 21% undervalued after recent price drop

Upcoming dividend of NT$4.50 per share at 4.2% yield

Bioteque Corporation Announces Chief Internal Auditor Changes

Now 20% undervalued

Bioteque Corporation Announces Executive Appointments

Full year 2022 earnings released: EPS: NT$7.12 (vs NT$6.22 in FY 2021)

Bioteque Corporation Announces Executive Changes

Third quarter 2022 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings: EPS exceeds analyst expectations

Bioteque Corporation Announces Change of Vice Chairman

Bioteque Corporation Announces Resignation of Tang-Lung Hsu as Natural-Person Director

Upcoming dividend of NT$4.50 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations

Bioteque Corporation Appoints Yiu-Cho Chin as Member of the Fifth Term of Compensation Committee

Bioteque Corporation Announces Resignation of Ren-Fang Li as Independent Director

Bioteque Corporation Appoints Members of the Fifth Term of Compensation Committee

Bioteque Corporation Announces Board Changes

First quarter 2022 earnings released: EPS: NT$1.76 (vs NT$1.74 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS NT$1.29 (vs NT$1.75 in 3Q 2020)

Upcoming dividend of NT$4.00 per share

Second quarter 2021 earnings released: EPS NT$1.31 (vs NT$1.56 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$1.74 (vs NT$1.57 in 1Q 2020)

A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)

Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?

Full year 2020 earnings released: EPS NT$7.05 (vs NT$6.70 in FY 2019)

Bioteque Corporation Approves Dividend Distribution of 2020 Profits

Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: NT$125

The Trends At Bioteque (GTSM:4107) That You Should Know About

Update: Bioteque (GTSM:4107) Stock Gained 51% In The Last Three Years

New 90-day low: NT$126

Estimating The Intrinsic Value Of Bioteque Corporation (GTSM:4107)

Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet

New 90-day low: NT$130

Does Bioteque Corporation (GTSM:4107) Have A Place In Your Dividend Portfolio?

Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Will Bioteque (GTSM:4107) Multiply In Value Going Forward?

Third quarter 2020 earnings released: EPS NT$1.75

Revenue misses expectations

New 90-day low: NT$132

New 90-day low - NT$133

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin